Zobrazeno 1 - 10
of 24
pro vyhledávání: '"John J Balser"'
Autor:
Maria L. Escolar, Susan Paadre, Asif M. Paker, Jean Hugues Dalle, Joanne Kurtzberg, Vinod K. Prasad, Paul J. Orchard, John J Balser, Gerald V. Raymond, Alain Fischer, Weston P. Miller, Patrick Aubourg, André Baruchel, David Nascene, Troy C. Lund, Stéphane Blanche, Gérard Michel
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:538-548
Cerebral adrenoleukodystrophy (CALD) is a rapidly progressing, often fatal neurodegenerative disease caused by mutations in the ABCD1 gene, resulting in deficiency of ALD protein. Clinical benefit has been reported following allogeneic hematopoietic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfdc0897483c685c6fd41865da693da9
https://doi.org/10.1016/j.bbmt.2018.09.036
https://doi.org/10.1016/j.bbmt.2018.09.036
Autor:
Haymond MW; Clinical Care Center, Texas Children's Hospital, Baylor College of Medicine, 6701 Fannin St., 11th floor, Houston, TX, 77030, USA. mhaymond@bcm.edu., Araújo-Vilar D; Thyroid and Metabolic Diseases Unit, Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS)-IDIS, School of Medicine, Universidade de Santiago de Compostela, Avda. Barcelona 3, Santiago de Compostela, 15707, Spain., Balser J; Veristat LLC, 134 Turnpike Rd #200, Southborough, MA, 01772, USA., Lewis JH; MedStar Georgetown University Hospital, Washington, DC, USA., Louzado R; Amryt Pharmaceuticals DAC, 45 Mespil Road, Dublin 4, Ireland., Musso C; Diabetes section, Fundacion Favaloro, Buenos Aires, Argentina., von Schnurbein J; Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Centre for Rare Endocrine Disorders, Ulm University Medical Centre, Eythstraße 24, 89075, Ulm, Germany., Wabitsch M; Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Centre for Rare Endocrine Disorders, Ulm University Medical Centre, Eythstraße 24, 89075, Ulm, Germany.
Publikováno v:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2023 May 26; Vol. 18 (1), pp. 127. Date of Electronic Publication: 2023 May 26.
Autor:
Pemmaraju N; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Lane AA; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Sweet KL; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Stein AS; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Vasu S; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Blum W; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Rizzieri DA; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Wang ES; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Duvic M; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Sloan JM; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Spence S; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Shemesh S; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Brooks CL; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Balser J; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Bergstein I; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Lancet JE; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Kantarjian HM; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York., Konopleva M; From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2019 Apr 25; Vol. 380 (17), pp. 1628-1637.
Autor:
Raymond GV; Pediatric Blood and Marrow Transplantation Center, University of Minnesota, Minneapolis, Minnesota., Aubourg P; Department of Neuropediatrics and INSERM UMR1169, University-Paris Sud, Le Kremlin-Bicêtre, France., Paker A; bluebird bio, Inc, Cambridge, Massachusetts., Escolar M; Department of Pediatrics, Children's Hospital of Pittsburg of UPMC, Pittsburgh, Pennsylvania., Fischer A; Department of Immunology, Hematology, and Pediatric Rheumatology, Necker Hospital for Sick Children, Paris, France., Blanche S; Department of Immunology, Hematology, and Pediatric Rheumatology, Necker Hospital for Sick Children, Paris, France., Baruchel A; Pediatric Hematology-Immunology Department, APHP, Robert Debré Hospital, Paris, France; Pediatric Hematology-Immunology Department, Paris Diderot University, Paris, France., Dalle JH; Department of Pediatric Hematology, APHP, Robert Debré Hospital, Paris Diderot University, Paris, France., Michel G; Department of Pediatric Hematology-Oncology, APHM, La Timone Hospital, Aix-Marseille University, Marseille, France., Prasad V; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina., Miller W; Pediatric Blood and Marrow Transplantation Center, University of Minnesota, Minneapolis, Minnesota., Paadre S; Veristat, Southborough, Massachusetts., Balser J; Veristat, Southborough, Massachusetts., Kurtzberg J; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina., Nascene DR; Department of Diagnostic Radiology, University of Minnesota, Minneapolis, Minnesota., Orchard PJ; Pediatric Blood and Marrow Transplantation Center, University of Minnesota, Minneapolis, Minnesota., Lund T; Pediatric Blood and Marrow Transplantation Center, University of Minnesota, Minneapolis, Minnesota. Electronic address: lundx072@umn.edu.
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Mar; Vol. 25 (3), pp. 538-548. Date of Electronic Publication: 2018 Oct 04.
Autor:
Labrie F; EndoCeutics Inc, Quebec City, Quebec, Canada., Archer DF; CONRAD Clinical Research Center, Norfolk, VA., Koltun W; Medical Center for Clinical Research, San Diego, CA., Vachon A; Clinique Médicale St-Louis (recherche) Inc, Quebec City, Quebec, Canada., Young D; Northern California Research, Sacramento, CA., Frenette L; Q&T Recherche Sherbrooke, Sherbrooke, Quebec, Canada., Portman D; Columbus Center for Women's Health Research, Columbus, OH., Montesino M; EndoCeutics Inc, Quebec City, Quebec, Canada., Côté I; EndoCeutics Inc, Quebec City, Quebec, Canada., Parent J; EndoCeutics Inc, Quebec City, Quebec, Canada., Lavoie L; EndoCeutics Inc, Quebec City, Quebec, Canada., BSc AB; EndoCeutics Inc, Quebec City, Quebec, Canada., Martel C; EndoCeutics Inc, Quebec City, Quebec, Canada., Vaillancourt M; EndoCeutics Inc, Quebec City, Quebec, Canada., Balser J; Veristat, Holliston, MA., Moyneur É; StatLog Consulting Inc, Ottawa, Ontario, Canada.
Publikováno v:
Menopause (New York, N.Y.) [Menopause] 2018 Nov; Vol. 25 (11), pp. 1339-1353.
Autor:
Lagutchik M; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Baker J; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Balser J; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Burghardt W; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Enroth M; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Flournoy S; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Giles J; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Grimm P; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Hiniker J; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Johnson J; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Mann K; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Takara M; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX., Thomas T; Joint Trauma System, 3698 Chambers Pass, Joint Base San Antonio, Fort Sam Houston, TX.
Publikováno v:
Military medicine [Mil Med] 2018 Sep 01; Vol. 183 (suppl_2), pp. 180-189.
Autor:
Martel C; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada., Labrie F; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada. Electronic address: fernand.labrie@endoceutics.com., Archer DF; CONRAD Clinical Research Center, Norfolk, VA, USA., Ke Y; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada., Gonthier R; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada., Simard JN; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada., Lavoie L; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada., Vaillancourt M; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada., Montesino M; EndoCeutics Inc., Quebec City, QC G1V 4M7, Canada., Balser J; Veristat, Southborough, MA, USA., Moyneur É; StatLog Consulting Inc., Quebec, QC, Canada.
Publikováno v:
The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2016 May; Vol. 159, pp. 142-53. Date of Electronic Publication: 2016 Mar 10.
Autor:
Labrie F; 1EndoCeutics Inc, Quebec City, Quebec, Canada 2CONRAD Clinical Research Center, Norfolk, VA 3Medical Center for Clinical Research, San Diego, CA 4Clinique Médicale St-Louis (recherche) Inc, Quebec City, Quebec, Canada 5Northern California Research, Sacramento, CA 6Q&T Recherche Sherbrooke, Sherbrooke, Quebec, Canada 7Columbus Center for Women's Health Research, Columbus, OH 8Veristat, Holliston, MA 9StatLog Consulting Inc, Ottawa, Ontario, Canada., Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Côté I, Parent J, Lavoie L, Beauregard A, Martel C, Vaillancourt M, Balser J, Moyneur É
Publikováno v:
Menopause (New York, N.Y.) [Menopause] 2016 Mar; Vol. 23 (3), pp. 243-56.
Autor:
Bouchard C, Labrie F, Derogatis L, Girard G, Ayotte N, Gallagher J, Cusan L, Archer DF, Portman D, Lavoie L, Beauregard A, Côté I, Martel C, Vaillancourt M, Balser J, Moyneur E
Publikováno v:
Hormone molecular biology and clinical investigation [Horm Mol Biol Clin Investig] 2016 Mar; Vol. 25 (3), pp. 181-90.
Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator.
Autor:
Montesino M; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Labrie F; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Archer DF; b Clinical Research Center, Eastern Virginia Medical School , Norfolk , VA , USA ., Zerhouni J; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Côté I; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Lavoie L; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Beauregard A; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Martel C; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Vaillancourt M; a EndoCeutics Inc , Quebec City , Quebec, G1V 4M7 , Canada ., Moyneur E; c StatLog Consulting Inc , Ottawa , ON , Canada , and., Balser J; d Veristat Inc. , Holliston , MA , USA.
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 2016; Vol. 32 (3), pp. 240-5. Date of Electronic Publication: 2016 Jan 06.